Prehabilitation: Optimizing Patients to Improve Outcomes - Part 2

IASLC Webinars Main image with Webinar Details
Overview

 

Prehabilitation is a multimodal strategy involving physical exercise as well as nutritional and psychosocial interventions aimed at improving fitness in the preoperative period. It is also used to improve and support patient tolerance and outcomes from treatments such as chemotherapy, radiotherapy, and immunotherapy.

Join a multidisciplinary team of nursing and allied health professionals as they discuss how prehabilitation can be used to optimize thoracic oncology patients prior to treatment and support them throughout their journey. This is part two of a two-part series that aims to comprehensively present the key aspects of prehabilitation, including a scientific overview of benefits, organizing a program, physical conditioning and strengthening strategies prior to and during treatment, nutritional support, and psychological/motivational support.

These webinars aim to address not only the reasons why prehabilitation is pivotal to optimizing patient care, and survivorship, but the wider scope of its implementation in the thoracic oncology cancer pathway.

Date
Jul 13, 2021 -
Jul 13, 2021
Location

Online

Tuesday, July 13 

2 PM MDT, 4 PM EDT, 9 PM UK, 10 PM CEST

Wednesday, July 14 

6 AM AEDT

A one-hour webinar consisting of three, 15-minute presentations on prehabilitation. There will be 15 minutes allotted to Q&A with the viewers.

At the conclusion of this activity, participants will be able to:
1. Summarize the rationale and evidence behind prehabilitation. This will include beneficial outcomes as functional capacity and reduced hospital stay. 
2. Describe objective measures used to determine functional capacity in patients with lung cancer.
3. Describe the role nutrition plays in the care of lung cancer patients before, during, and after treatment.
4. Explain the emotional concerns lung cancer patients may have related to pre-habilitation and describe supportive strategies. 

This webinar is designed to meet the educational needs of physicians, researchers, patient advocates, and nurse and allied health professionals specializing in palliative care, medical oncology, radiation oncology, and thoracic surgery.

Accreditation Statement
The International Association for the Study of Lung Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The International Association for the Study of Lung Cancer designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Stephen Wootton, PhD, FAfN, OBE discloses he is on an advisory board and has an investigator-led institutional collaborative research agreement with Seca GmBH.

None of the other planners, reviewers, and staff for this activity reported any relevant financial relationships.

Tuesday, July 13 

2 PM MDT, 4 PM EDT, 9 PM UK, 10 PM CEST

Wednesday, July 14 

6 AM AEDT

A one-hour webinar consisting of three, 15-minute presentations on prehabilitation. There will be 15 minutes allotted to Q&A with the viewers.

At the conclusion of this activity, participants will be able to:
1. Summarize the rationale and evidence behind prehabilitation. This will include beneficial outcomes as functional capacity and reduced hospital stay. 
2. Describe objective measures used to determine functional capacity in patients with lung cancer.
3. Describe the role nutrition plays in the care of lung cancer patients before, during, and after treatment.
4. Explain the emotional concerns lung cancer patients may have related to pre-habilitation and describe supportive strategies. 

This webinar is designed to meet the educational needs of physicians, researchers, patient advocates, and nurse and allied health professionals specializing in palliative care, medical oncology, radiation oncology, and thoracic surgery.

Accreditation Statement
The International Association for the Study of Lung Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The International Association for the Study of Lung Cancer designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Stephen Wootton, PhD, FAfN, OBE discloses he is on an advisory board and has an investigator-led institutional collaborative research agreement with Seca GmBH.

None of the other planners, reviewers, and staff for this activity reported any relevant financial relationships.

Share

Participants

Morton Quist
Dr. Morten Quist

PT, PhD

Associate Professor, Body & Cancer
University of Copenhagen
University Hospital of Copenhagen, Rigshospitalet Copenhagen, Denmark
Dr. Wootton
Dr. Stephen Wootton

PhD, FAfN, OBE

Associate Professor, Human Nutrition; Deputy Chair, National Institute of health research Cancer & Nutrition Collaboration
University of Southampton, Southampton, England
Christina Prickett
Dr. Christina Prickett

DPsych

Clinical Psychologist
Peter MacCallum Cancer Centre Melbourne, Australia
Pippa Labuc
Pippa Labuc

BScOT

Moderator - Clinical Specialist Occupational Therapist
Guy's and St. Thomas' NHS Foundation Trust London, United Kingdom